Intra-abdominal infections: Analysis of current guidelines;Terapia: Linee guida esistenti per il trattamento delle infezioni intraddominali

Infezioni in Medicina

Volumn 16, Issue SUPPL. 1, 2008, Pages 46-52

  Esposito, Silvano ^a   Carosi, Gianpiero ^b   Leone, Sebastiano ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Guidelines; Inadequate antibiotic therapy; Intra abdominal infections

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CLAVULANIC ACID; CLINDAMYCIN; ERTAPENEM; GATIFLOXACIN; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NITROIMIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; TIMENTIN;

ABDOMINAL INFECTION; AEROBE; ANAEROBE; ANTIBIOTIC THERAPY; EVIDENCE BASED PRACTICE; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION; INFECTION; LENGTH OF STAY; MICROORGANISM; MORBIDITY; MORTALITY; PERITONITIS; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; REVIEW; TREATMENT DURATION;

ABDOMINAL CAVITY; ANTI-BACTERIAL AGENTS; COST OF ILLNESS; CROSS INFECTION; DIGESTIVE SYSTEM DISEASES; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MICROBIAL SENSITIVITY TESTS; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS;

EID: 42049084150     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Kish M.A. Guide to development of practice guidelines. Clin. Infect. Dis. 32, 851-854, 2001.
2. Solomkin J.S., Mazuski J.E., Baron E.J., et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin. Infect. Dis. 37: 997-1005, 2003.
3. Laterre P.F., Colardyn F., Delmee M., et al. Antimicrobial therapy for intra-abdominal infections: guidelines from the Infectious Disease Advisory Board (IDAB). Acta. Chir. Belg. 106:2-21, 2006.
4. Mazuski J.E., Sawyer R.G., Nathens A.B., et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg. Infect. 3: 161-173, 2002.
5. Tellado J.M., Sitges-Serra A., Barcenilla F., et al. Pautas de tratamiento antibiótico empírico de las infecciones infraabdominales. Emergencias 17, 221-227, 2005.
6. Bohnen J.M., Solomkin J.S., Dellinger E.P., et al. Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A surgical infection society policy statement. Arch. Surg. 127, 83-89, 1992.
7. De Lalla F. Le infezioni endoaddominali: classificazione e microbiologia. Quaderni SITA. 2005.
8. Roehrborn A., Thomas L., Potreck O., et al. The microbiology of postoperative peritonitis. Clin. Infect. Dis. 33, 1513-1519, 2001.
9. Eggimann P., Francioli P., Bille J., et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit. Care Med. 27, 1066-1072, 1999.
10. Baré M., Castells X., Garcia A., et al. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections. Int. J. Technol. Assess. Health. Care. 22, 242-248, 2006.
11. Sturkenboom M.C., Goettsch W.G., Picelli G., et al. Inappropriate initial treatment of secondary intraabdominal infections leads to increased risk of clinical failure and costs. Br. J. Clin. Pharmacol. 60, 438-443, 2005.
12. Montravers P., Gauzit R., Muller C., et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin. Infect. Dis. 23, 486-494, 2000.
13. Hedrick T.L., Sawyer R.G. Duration of antibiotic therapy for intra-abdominal infections. Infect. Med. 21, 506-510, 2004.
14. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31 (Suppl 4), 131-138, 2000.